Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
darovasertib (IDE196)
i
Other names:
IDE196, LXS-196, LXS 196, LXS196, IDE-196, IDE 196
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(9)
News
Trials
Company:
Ideaya Biosci, Novartis
Drug class:
PKC inhibitor
Related drugs:
‹
AEB071 (17)
AHT956 (2)
RO-31-8220 (2)
K-252a (1)
AEB071 (17)
AHT956 (2)
RO-31-8220 (2)
K-252a (1)
›
Associations
(9)
News
Trials
VERI cancer hierarchy
Reset Filters
GNA11 Q209L
Uveal Melanoma
GNA11 Q209L
Uveal Melanoma
IDE196
Sensitive: C3 – Early Trials
IDE196
Sensitive
:
C3
IDE196
Sensitive: C3 – Early Trials
IDE196
Sensitive
:
C3
PRKCH-SPTB fusion
Cutaneous Melanoma
PRKCH-SPTB fusion
Cutaneous Melanoma
IDE196
Sensitive: D – Preclinical
IDE196
Sensitive
:
D
IDE196
Sensitive: D – Preclinical
IDE196
Sensitive
:
D
PRKCH fusion
Cutaneous Melanoma
PRKCH fusion
Cutaneous Melanoma
IDE196
Sensitive: D – Preclinical
IDE196
Sensitive
:
D
IDE196
Sensitive: D – Preclinical
IDE196
Sensitive
:
D
PRKCH fusion
Colorectal Cancer
PRKCH fusion
Colorectal Cancer
IDE196
Resistant: D – Preclinical
IDE196
Resistant
:
D
IDE196
Resistant: D – Preclinical
IDE196
Resistant
:
D
PRKCH-SPTB fusion
Colorectal Cancer
PRKCH-SPTB fusion
Colorectal Cancer
IDE196
Sensitive: D – Preclinical
IDE196
Sensitive
:
D
IDE196
Sensitive: D – Preclinical
IDE196
Sensitive
:
D
PRKCH-VWA2 fusion
Colorectal Cancer
PRKCH-VWA2 fusion
Colorectal Cancer
IDE196
Sensitive: D – Preclinical
IDE196
Sensitive
:
D
IDE196
Sensitive: D – Preclinical
IDE196
Sensitive
:
D
HIF1A-PRKCH fusion
Colorectal Cancer
HIF1A-PRKCH fusion
Colorectal Cancer
IDE196
Sensitive: D – Preclinical
IDE196
Sensitive
:
D
IDE196
Sensitive: D – Preclinical
IDE196
Sensitive
:
D
HIF1A-PRKCH fusion
Cutaneous Melanoma
HIF1A-PRKCH fusion
Cutaneous Melanoma
IDE196
Resistant: D – Preclinical
IDE196
Resistant
:
D
IDE196
Resistant: D – Preclinical
IDE196
Resistant
:
D
PRKCH-VWA2 fusion
Cutaneous Melanoma
PRKCH-VWA2 fusion
Cutaneous Melanoma
IDE196
Sensitive: D – Preclinical
IDE196
Sensitive
:
D
IDE196
Sensitive: D – Preclinical
IDE196
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login